Early data for heart drug affirm Lilly’s billion-dollar bet on Verve
This story is reported by BioPharma Dive. Read what other outlets are saying below, then open the original report for full details.
This story is reported by BioPharma Dive. Read what other outlets are saying below, then open the original report for full details.